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469 Decellularization reduces the immune response to aortic valve allografts in
the rat
Steven R. Meyer, MD, Jeevan Nagendran, BSc, Leena S. Desai, Gina R. Rayat, PhD,
Thomas A. Churchill, PhD, Colin C. Anderson, PhD, Ray V. Rajotte, PhD,
Jonathan R. T. Lakey, PhD, and David B. Ross, MD, Edmonton, Alberta, Canada
Cryopreserved valve allografts are essential for many procedures performed in congenital
cardiac surgery but are highly immunogenic, causing failure and sensitization. Decellularization
might reduce the immunogenicity of these tissues. Results demonstrated that decellularization
significantly reduces both cellular and humoral immune responses in a rat allograft valve
model.
477 Transcatheter placement of a low-profile biodegradable pulmonary valve
made of small intestinal submucosa: A long-term study in a swine model
Carlos E. Ruiz, MD, PhD, Motofumi Iemura, MD, Sibyl Medie, MS, Peter Varga, MD,
William G. Van Alstine, DVM, PhD, Susan Mack, BA, Anna Deligio, CRT, Neal Fearnot, PhD,
Ulf H. Beier, MD, PhD, Dusan Pavcnik, MD, PhD, Ziyad M. Hijazi, MD, and
Matti Kiupel, DVM, PhD, Chicago, Ill, West Lafayette, Ind, Portland, Ore, and East Lansing, Mich
A percutaneously placed valve based on small intestinal submucosa (SIS) material has been
studied in a porcine model. Echocardiographic and histologic data suggest a potential for
prolonged graft longevity of the SIS valve without the need for anticoagulation or
immunosuppression.
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485 Risk factors for late stroke after coronary artery bypass grafting
Thomas Schachner, MD, Anne Zimmer, Georg Nagele, MD, Guenther Laufer, MD, and
Johannes Bonatti, MD, Innsbruck, Austria
In patients undergoing intraoperative epiaortic ultrasonography of the ascending aorta during
CABG, the following risk factors for the long-term occurrence of strokes could be identified:
age of 70 years or more, preoperative unstable angina, chronic obstructive pulmonary disease,
carotid artery disease, history of neurologic events, and a maximum ascending aortic wall
thickness of 4 mm or greater.
491 Surgical ablation of atrial fibrillation with a novel bipolar radiofrequency
device
Stefano Benussi, MD, PhD, Simona Nascimbene, MD, Giliola Calori, MD, Paolo Denti, MD,
Zvi Ziskind, MD, Samer Kassem, MD, Giovanni La Canna, MD, Carlo Pappone, MD, PhD,
and Ottavio Alfieri, MD, Milan, Italy
Epicardial ablation with bipolar radiofrequency was used for the concomitant treatment of AF in 90
patients. Acutely, pulmonary vein isolation was attained in all cases. Eighty-nine percent of the
patients were in sinus rhythm 1 year after surgery. A 7% rate of left atrial flutter was recorded.
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